Drug Information

General Information
Drug ID
DR01121
Drug Name
Taurocholic acid
Synonyms
2-((3-alpha,7-alpha,12-alpha-Trihydroxy-24-oxo-5-be ta-cholan-24-yl)amino)ethanesulfonic acid; 3alpha,7alpha,12alpha-Trihydroxy-5beta-cholanic acid 24-taurine; 81-24-3; Acidum cholatauricum; C26H45NO7S; Cholaic acid; Cholic acid taurine conjugate; Cholyltaurine; EINECS 201-336-2; Ethanesulfonic acid, 2-(((3alpha,5beta,7alpha,12alpha)-3,7,12-trihydroxy-24-oxocholan-24-yl)amino)-; HSDB 832; N-Choloyltaurine; NSC 25505; NSC25505; TAUROCHOLIC ACID; Taurine Cholate; Taurine, N-choloyl-; Taurocholate; Taurocholic acid; UNII-5E090O0G3Z; [3H]taurocholic acid
Drug Type
Small molecular drug
Indication Type 2 diabetes [ICD11: 5A11] Terminated [1]
Structure
3D MOL 2D MOL
Formula
C26H45NO7S
Canonical SMILES
CC(CCC(=O)NCCS(=O)(=O)O)C1CCC2C1(C(CC3C2C(CC4C3(CCC(C4)O)C)O)O)C
InChI
InChI=1S/C26H45NO7S/c1-15(4-7-23(31)27-10-11-35(32,33)34)18-5-6-19-24-20(14-22(30)26(18,19)3)25(2)9-8-17(28)12-16(25)13-21(24)29/h15-22,24,28-30H,4-14H2,1-3H3,(H,27,31)(H,32,33,34)/t15-,16+,17-,18-,19+,20+,21-,22+,24+,25+,26-/m1/s1
InChIKey
WBWWGRHZICKQGZ-HZAMXZRMSA-N
CAS Number
CAS 81-24-3
Pharmaceutical Properties Molecular Weight 515.7 Topological Polar Surface Area 153
Heavy Atom Count 35 Rotatable Bond Count 7
Hydrogen Bond Donor Count 5 Hydrogen Bond Acceptor Count 7
XLogP
2.2
PubChem CID
6675
PubChem SID
103512877 , 104312745 , 119526221 , 125311155 , 125311164 , 134972658 , 135750992 , 137102321 , 137202600 , 138724705 , 144080928 , 14717827 , 15805741 , 160854684 , 162224002 , 163138205 , 164779365 , 17422067 , 176484548 , 178101267 , 178101268 , 179323898 , 198948969 , 224772447 , 226395830 , 252497719 , 29225628 , 4266393 , 47439969 , 49748546 , 50065243 , 50397873 , 53789715 , 57323632 , 605316 , 8138084 , 8154316 , 828139 , 841389 , 86672 , 92309274 , 93167213
ChEBI ID
CHEBI:28865
TTD Drug ID
D09NTG
DT(s) Transporting This Drug ASBT Transporter Info Apical sodium-dependent bile acid transporter Substrate [2]
BCRP Transporter Info Breast cancer resistance protein Substrate [3]
BSEP Transporter Info Bile salt export pump Substrate [4]
MRP3 Transporter Info Multidrug resistance-associated protein 3 Substrate [5]
MRP4 Transporter Info Multidrug resistance-associated protein 4 Substrate [6]
NTCP Transporter Info Sodium/taurocholate cotransporting polypeptide Substrate [7]
OATP1A2 Transporter Info Organic anion transporting polypeptide 1A2 Substrate [8]
OATP1B1 Transporter Info Organic anion transporting polypeptide 1B1 Substrate [9]
OATP1B3 Transporter Info Organic anion transporting polypeptide 1B3 Substrate [10]
OATP2B1 Transporter Info Organic anion transporting polypeptide 2B1 Substrate [11]
OATP4A1 Transporter Info Organic anion transporting polypeptide 4A1 Substrate [12]
OSTalpha Transporter Info Organic solute transporter subunit alpha Substrate [13]
OSTbeta Transporter Info Organic solute transporter subunit beta Substrate [13]
Drug-Transporter Activity Data
Drug-Transporter Activity Data ASBT Transporter Info Km = 9.4 microM Human embryonic kidney cells (HEK293)-ASBT [2]
ASBT Transporter Info Km = 13.3 microM Monkey kidney fibroblast-like cell (COS)1-ASBT [14]
BSEP Transporter Info Km = 4.25 microM High five cells-BSEP [15]
NTCP Transporter Info Km = 7.9 microM Human cervical cancer cell line (Hela)-NTCP [7]
NTCP Transporter Info Km = 6.2 microM Oocytes-NTCP [16]
OATP1A2 Transporter Info Km = 15.9 microM Human embryonic kidney cells (HEK293)-OATP1A2 [8]
OATP1A2 Transporter Info Km = 64 microM Human liver cancer cells (HepG2)-OATP1A2 [17]
OATP1A2 Transporter Info Km = 60 microM Oocytes-OATP1A2 [18]
OATP1B1 Transporter Info Km = 33.8 microM Human embryonic kidney cells (HEK293)-OATP1B1 [19]
OATP1B1 Transporter Info Km = 13.6 microM Oocytes-OATP1B1 [9]
OATP2B1 Transporter Info Km = 71.8 microM Human embryonic kidney cells (HEK293)-OATP2B1 [11]
OATP4A1 Transporter Info Km = 14.9 microM Oocytes-OATP4A1 [12]
References
1 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800033000)
2 Identification of a region of the ileal-type sodium/bile acid cotransporter interacting with a competitive bile acid transport inhibitor. Biochemistry. 2002 Dec 17;41(50):14916-24.
3 Characterization of the role of ABCG2 as a bile acid transporter in liver and placenta. Mol Pharmacol. 2012 Feb;81(2):273-83.
4 Inhibition of transport across the hepatocyte canalicular membrane by the antibiotic fusidate. Biochem Pharmacol. 2002 Jul 1;64(1):151-8.
5 Characterization of the role of polar amino acid residues within predicted transmembrane helix 17 in determining the substrate specificity of multidrug resistance protein 3. Biochemistry. 2003 Aug 26;42(33):9989-10000.
6 Human intestinal transporter database: QSAR modeling and virtual profiling of drug uptake, efflux and interactions. Pharm Res. 2013 Apr;30(4):996-1007.
7 Modulation by drugs of human hepatic sodium-dependent bile acid transporter (sodium taurocholate cotransporting polypeptide) activity. J Pharmacol Exp Ther. 1999 Dec;291(3):1204-9.
8 Identification of multiple binding sites for substrate transport in bovine organic anion transporting polypeptide 1a2. Drug Metab Dispos. 2013 Mar;41(3):602-7.
9 Identification of a novel gene family encoding human liver-specific organic anion transporter LST-1. J Biol Chem. 1999 Jun 11;274(24):17159-63.
10 Effect of pregnane X receptor ligands on transport mediated by human OATP1B1 and OATP1B3. Eur J Pharmacol. 2008 Apr 14;584(1):57-65.
11 Functional characterization of pH-sensitive organic anion transporting polypeptide OATP-B in human. J Pharmacol Exp Ther. 2004 Feb;308(2):438-45.
12 Identification of thyroid hormone transporters in humans: different molecules are involved in a tissue-specific manner. Endocrinology. 2001 May;142(5):2005-12.
13 Functional complementation between a novel mammalian polygenic transport complex and an evolutionarily ancient organic solute transporter, OSTalpha-OSTbeta. J Biol Chem. 2003 Jul 25;278(30):27473-82.
14 Expression and transport properties of the human ileal and renal sodium-dependent bile acid transporter. Am J Physiol. 1998 Jan;274(1 Pt 1):G157-69.
15 The human bile salt export pump: characterization of substrate specificity and identification of inhibitors. Gastroenterology. 2002 Nov;123(5):1649-58.
16 Molecular cloning, chromosomal localization, and functional characterization of a human liver Na+/bile acid cotransporter. J Clin Invest. 1994 Mar;93(3):1326-31.
17 Molecular and functional characterization of bile acid transport in human hepatoblastoma HepG2 cells. Hepatology. 1996 May;23(5):1053-60.
18 Molecular and functional characterization of an organic anion transporting polypeptide cloned from human liver. Gastroenterology. 1995 Oct;109(4):1274-82.
19 A novel human hepatic organic anion transporting polypeptide (OATP2). Identification of a liver-specific human organic anion transporting polypeptide and identification of rat and human hydroxymethylglutaryl-CoA reductase inhibitor transporters. J Biol Chem. 1999 Dec 24;274(52):37161-8.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.